The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
Stanford University medical professor Dr. Bryant Lin was diagnosed with stage IV lung cancer despite never smoking. Now, he's ...
Learn how a young woman diagnosed with stage 4 non-small cell lung cancer had many treatment options because she came to MSK first.
A new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most ...
Rhode Island ranked second for its lung cancer survival rate, with more than 35% living five years post diagnosis. The state ...
By: Nicola MawsonAnyone who has seen a loved one battle lung cancer will tell you just how debilitating it is, watching them ...
Floridians are at high risk for lung cancer, and many are waiting too long to get screened, which affects their survival rate ...
Dr. Heba Ismail at Sutter Health’s California Pacific Medical Center has dedicated her career to the early detection and ...
Based on ADRIATIC Phase III trial results which showed a 27% reduction in the risk of death versus placebo AstraZeneca's IMFINZI (durvalumab) has been approved in the US for the treatment of adult ...
Discover the heightened thromboembolic risk for metastatic lung cancer patients on immune checkpoint inhibitors. Learn about ...
According to the American Lung Association, biomarker testing gaps and low screening rates continue to hinder lung cancer ...